These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 21176158)

  • 1. Cost-effectiveness of six strategies for Helicobacter pylori diagnosis and management in uninvestigated dyspepsia assuming a high resource intensity practice pattern.
    Holmes KP; Fang JC; Jackson BR
    BMC Health Serv Res; 2010 Dec; 10():344. PubMed ID: 21176158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reappraisal of non-invasive management strategies for uninvestigated dyspepsia: a cost-minimization analysis.
    Ladabaum U; Chey WD; Scheiman JM; Fendrick AM
    Aliment Pharmacol Ther; 2002 Aug; 16(8):1491-501. PubMed ID: 12182749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Helicobacter pylori eradication in long-term proton pump inhibitor users is highly cost-effective: economic analysis of the HELPUP trial.
    Mason JM; Raghunath AS; Hungin AP; Jackson W
    Aliment Pharmacol Ther; 2008 Dec; 28(11-12):1297-303. PubMed ID: 18793340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Helicobacter pylori test and treat versus proton pump inhibitor in initial management of dyspepsia in primary care: multicentre randomised controlled trial (MRC-CUBE trial).
    Delaney BC; Qume M; Moayyedi P; Logan RF; Ford AC; Elliott C; McNulty C; Wilson S; Hobbs FD
    BMJ; 2008 Mar; 336(7645):651-4. PubMed ID: 18310262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of noninvasive testing and treatment strategies for H. pylori infection in children with dyspepsia.
    Vakil N; Ashorn M
    Am J Gastroenterol; 1998 Apr; 93(4):562-8. PubMed ID: 9576448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment-Helicobacter pylori positive (CADET-Hp) randomised controlled trial.
    Chiba N; Van Zanten SJ; Sinclair P; Ferguson RA; Escobedo S; Grace E
    BMJ; 2002 Apr; 324(7344):1012-6. PubMed ID: 11976244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic evaluation of Helicobacter pylori eradication in the CADET-Hp randomized controlled trial of H. pylori-positive primary care patients with uninvestigated dyspepsia.
    Chiba N; Veldhuyzen Van Zanten SJ; Escobedo S; Grace E; Lee J; Sinclair P; Barkun A; Armstrong D; Thomson AB
    Aliment Pharmacol Ther; 2004 Feb; 19(3):349-58. PubMed ID: 14984382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management strategies for Helicobacter pylori-seropositive patients with dyspepsia: clinical and economic consequences.
    Ofman JJ; Etchason J; Fullerton S; Kahn KL; Soll AH
    Ann Intern Med; 1997 Feb; 126(4):280-91. PubMed ID: 9036800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic evaluation of empirical antisecretory therapy versus Helicobacter pylori test for management of dyspepsia: a randomized trial in primary care.
    Jarbol DE; Bech M; Kragstrup J; Havelund T; Schaffalitzky de Muckadell OB
    Int J Technol Assess Health Care; 2006; 22(3):362-71. PubMed ID: 16984065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cost-effectiveness of population Helicobacter pylori screening and treatment: a Markov model using economic data from a randomized controlled trial.
    Mason J; Axon AT; Forman D; Duffett S; Drummond M; Crocombe W; Feltbower R; Mason S; Brown J; Moayyedi P;
    Aliment Pharmacol Ther; 2002 Mar; 16(3):559-68. PubMed ID: 11876711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
    Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
    Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The management of Helicobacter pylori infection in primary care: a systematic review of the literature.
    Childs S; Roberts A; Meineche-Schmidt V; de Wit N; Rubin G
    Fam Pract; 2000 Aug; 17 Suppl 2():S6-11. PubMed ID: 10960429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the dyspeptic patient: a cost-utility study.
    Ebell MH; Warbasse L; Brenner C
    J Fam Pract; 1997 Jun; 44(6):545-55. PubMed ID: 9191627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Test and treat strategies for Helicobacter pylori in uninvestigated dyspepsia: a Canadian economic analysis.
    Marshall JK; Armstrong D; O'Brien BJ
    Can J Gastroenterol; 2000 May; 14(5):379-88. PubMed ID: 10851277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Yields of dual therapy containing high-dose proton pump inhibitor in eradication of H. pylori positive dyspeptic patients.
    Ince AT; Tozlu M; Baysal B; Şentürk H; Arıcı S; Özden A
    Hepatogastroenterology; 2014; 61(133):1454-8. PubMed ID: 25436324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of and satisfaction with a Helicobacter pylori "test and treat" strategy compared with prompt endoscopy in young Asians with dyspepsia.
    Mahadeva S; Chia YC; Vinothini A; Mohazmi M; Goh KL
    Gut; 2008 Sep; 57(9):1214-20. PubMed ID: 18441005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial management strategies for dyspepsia.
    Delaney B; Ford AC; Forman D; Moayyedi P; Qume M
    Cochrane Database Syst Rev; 2005 Oct; (4):CD001961. PubMed ID: 16235292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of a Helicobacter pylori treatment strategy on health care expenditures in patients with peptic ulcer disease and dyspepsia.
    Kearney DJ; Liu CF; Crump C; Brousal A
    Am J Gastroenterol; 2003 Sep; 98(9):1952-62. PubMed ID: 14499771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninvasive Helicobacter pylori testing for the "test-and-treat" strategy: a decision analysis to assess the effect of past infection on test choice.
    Chey WD; Fendrick AM
    Arch Intern Med; 2001 Sep; 161(17):2129-32. PubMed ID: 11570943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost effectiveness analysis of population-based serology screening and (13)C-Urea breath test for Helicobacter pylori to prevent gastric cancer: a markov model.
    Xie F; Luo N; Lee HP
    World J Gastroenterol; 2008 May; 14(19):3021-7. PubMed ID: 18494053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.